Details for New Drug Application (NDA): 050670
✉ Email this page to a colleague
NDA 050670 describes ZITHROMAX, which is a drug marketed by Pfizer and is included in seven NDAs. It is available from nine suppliers. Additional details are available on the ZITHROMAX profile page.
The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the azithromycin profile page.
The generic ingredient in ZITHROMAX is azithromycin. There are thirty-two drug master file entries for this compound. Sixty-eight suppliers are listed for this compound. Additional details are available on the azithromycin profile page.
Summary for 050670
| Tradename: | ZITHROMAX |
| Applicant: | Pfizer |
| Ingredient: | azithromycin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 050670
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | EQ 250MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Nov 1, 1991 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
